FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088957014> ?p ?o ?g. }

• W2088957014 endingPage "144" @default.
• W2088957014 startingPage "137" @default.
• W2088957014 abstract "Oral phosphodiesterase (PDE) 4 inhibitors have demonstrated clinical efficacy in chronic obstructive pulmonary disease and asthma. Preclinical and clinical investigation of inhaled PDE4 inhibitors is ongoing. 6-({3-[(Dimethylamino)carbonyl]phenyl}sulfonyl)-8-methyl-4-{[3-methyloxy)phenyl]amino}-3-quinolinecarboxamide (GSK256066) is an exceptionally high-affinity and selective inhibitor of PDE4 designed for inhaled delivery. The aim of these studies was to investigate the potency, duration of action, and therapeutic index of GSK256066 in animal models of pulmonary inflammation. The effects of intratracheally administered GSK256066 were investigated in rat lipopolysaccharide (LPS)- and ovalbumin (OVA)-induced models of acute pulmonary inflammation. In some studies, fluticasone propionate (FP) was included as a comparator. The therapeutic index (anti-inflammatory effect versus emesis) of GSK256066 was studied in ferrets where acute pulmonary inflammation was induced with inhaled LPS. In rats, GSK256066 and FP caused significant (p < 0.05) inhibition of LPS-induced pulmonary neutrophilia. The duration of action of GSK256066 at 10 × ED(50) dose (10 μg/kg) was 12 h. GSK256066 and FP also inhibited LPS-induced increases in exhaled nitric oxide (ED(50) 35 and 92 μg/kg, respectively). In addition, GSK256066 inhibited pulmonary eosinophilia in rats exposed to OVA (ED(50) 0.4 μg/kg). In ferrets, inhaled GSK256066 inhibited LPS-induced pulmonary neutrophilia (ED(50) 18 μg/kg), and no emetic episodes were observed. Thus, GSK256066 may have an improved therapeutic index compared with oral PDE4 inhibitors, e.g., cilomilast and roflumilast. In summary, GSK256066 demonstrates potent and long-lasting anti-inflammatory effects in animal models of pulmonary inflammation and does not induce emetic episodes in ferrets. GSK256066 has potential as an inhaled therapeutic for the treatment of asthma and chronic obstructive pulmonary disease." @default.
• W2088957014 created "2016-06-24" @default.
• W2088957014 creator A5005572883 @default.
• W2088957014 creator A5019043835 @default.
• W2088957014 creator A5030691488 @default.
• W2088957014 creator A5032968420 @default.
• W2088957014 creator A5066172333 @default.
• W2088957014 creator A5091837489 @default.
• W2088957014 date "2011-01-04" @default.
• W2088957014 modified "2023-10-02" @default.
• W2088957014 title "In Vivo Characterization of GSK256066, a High-Affinity Inhaled Phosphodiesterase 4 Inhibitor" @default.
• W2088957014 cites W1598648925 @default.
• W2088957014 cites W1930109984 @default.
• W2088957014 cites W1976969572 @default.
• W2088957014 cites W1989697230 @default.
• W2088957014 cites W1994226794 @default.
• W2088957014 cites W2017659011 @default.
• W2088957014 cites W2022497238 @default.
• W2088957014 cites W2026527102 @default.
• W2088957014 cites W2028109077 @default.
• W2088957014 cites W2029347209 @default.
• W2088957014 cites W2029944874 @default.
• W2088957014 cites W2031880739 @default.
• W2088957014 cites W2045875906 @default.
• W2088957014 cites W2069918438 @default.
• W2088957014 cites W2097771640 @default.
• W2088957014 cites W2101175089 @default.
• W2088957014 cites W2119070768 @default.
• W2088957014 cites W2141323574 @default.
• W2088957014 cites W2151950207 @default.
• W2088957014 cites W2154616892 @default.
• W2088957014 cites W2171216672 @default.
• W2088957014 cites W4237807778 @default.
• W2088957014 cites W83621033 @default.
• W2088957014 doi "https://doi.org/10.1124/jpet.110.173641" @default.
• W2088957014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21205924" @default.
• W2088957014 hasPublicationYear "2011" @default.
• W2088957014 type Work @default.
• W2088957014 sameAs 2088957014 @default.
• W2088957014 citedByCount "43" @default.
• W2088957014 countsByYear W20889570142012 @default.
• W2088957014 countsByYear W20889570142013 @default.
• W2088957014 countsByYear W20889570142014 @default.
• W2088957014 countsByYear W20889570142015 @default.
• W2088957014 countsByYear W20889570142016 @default.
• W2088957014 countsByYear W20889570142017 @default.
• W2088957014 countsByYear W20889570142018 @default.
• W2088957014 countsByYear W20889570142019 @default.
• W2088957014 countsByYear W20889570142020 @default.
• W2088957014 countsByYear W20889570142021 @default.
• W2088957014 countsByYear W20889570142022 @default.
• W2088957014 crossrefType "journal-article" @default.
• W2088957014 hasAuthorship W2088957014A5005572883 @default.
• W2088957014 hasAuthorship W2088957014A5019043835 @default.
• W2088957014 hasAuthorship W2088957014A5030691488 @default.
• W2088957014 hasAuthorship W2088957014A5032968420 @default.
• W2088957014 hasAuthorship W2088957014A5066172333 @default.
• W2088957014 hasAuthorship W2088957014A5091837489 @default.
• W2088957014 hasConcept C126322002 @default.
• W2088957014 hasConcept C150903083 @default.
• W2088957014 hasConcept C185592680 @default.
• W2088957014 hasConcept C19831878 @default.
• W2088957014 hasConcept C202751555 @default.
• W2088957014 hasConcept C203014093 @default.
• W2088957014 hasConcept C207001950 @default.
• W2088957014 hasConcept C2776042228 @default.
• W2088957014 hasConcept C2776780178 @default.
• W2088957014 hasConcept C2776914184 @default.
• W2088957014 hasConcept C2776946954 @default.
• W2088957014 hasConcept C2777037409 @default.
• W2088957014 hasConcept C2777802486 @default.
• W2088957014 hasConcept C2778754761 @default.
• W2088957014 hasConcept C2778926808 @default.
• W2088957014 hasConcept C2779028295 @default.
• W2088957014 hasConcept C2780035454 @default.
• W2088957014 hasConcept C2909466502 @default.
• W2088957014 hasConcept C55493867 @default.
• W2088957014 hasConcept C57992300 @default.
• W2088957014 hasConcept C71924100 @default.
• W2088957014 hasConcept C86803240 @default.
• W2088957014 hasConcept C8891405 @default.
• W2088957014 hasConcept C98274493 @default.
• W2088957014 hasConceptScore W2088957014C126322002 @default.
• W2088957014 hasConceptScore W2088957014C150903083 @default.
• W2088957014 hasConceptScore W2088957014C185592680 @default.
• W2088957014 hasConceptScore W2088957014C19831878 @default.
• W2088957014 hasConceptScore W2088957014C202751555 @default.
• W2088957014 hasConceptScore W2088957014C203014093 @default.
• W2088957014 hasConceptScore W2088957014C207001950 @default.
• W2088957014 hasConceptScore W2088957014C2776042228 @default.
• W2088957014 hasConceptScore W2088957014C2776780178 @default.
• W2088957014 hasConceptScore W2088957014C2776914184 @default.
• W2088957014 hasConceptScore W2088957014C2776946954 @default.
• W2088957014 hasConceptScore W2088957014C2777037409 @default.
• W2088957014 hasConceptScore W2088957014C2777802486 @default.
• W2088957014 hasConceptScore W2088957014C2778754761 @default.
• W2088957014 hasConceptScore W2088957014C2778926808 @default.
• W2088957014 hasConceptScore W2088957014C2779028295 @default.

• next